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Introduction {#sec005}
============

Glaucoma continues to be a frequent complication of penetrating keratoplasty (PK) and has been determined to be a primary cause of graft failure \[[@pone.0176261.ref001]\], with yet unexplained determinants. It has also been reported to be one of the three most common causes for graft failure along with rejection and infection \[[@pone.0176261.ref002]--[@pone.0176261.ref005]\]. The reported prevalence of glaucoma or ocular hypertension after PK varies remarkably \[[@pone.0176261.ref006]\], ranging from 5.3% \[[@pone.0176261.ref007]\] to 60% \[[@pone.0176261.ref008]\] according to the published literature, of which an important potential reason is lacking an universally recognized "gold-standard" of diagnosis. Also, the factors that contribute to clinically significant glaucoma after PK have not been fully established and are currently a matter of vital importance, which emphasizes the need for further investigation and to identify variables that can be modified to control intraocular pressure (IOP) after PK.

The objective of this meta-analysis was to identify all currently published literature to establish the incidence of post-penetrating keratoplasty glaucoma (PPKG), along with its major confounding factors, and its risk factors.

Materials and methods {#sec006}
=====================

Study selection {#sec007}
---------------

A systematic review of the published literature on PPKG was conducted following the Meta-Analysis of Observational Studies in Epidemiology (MOOSE)\[[@pone.0176261.ref009]\] and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines ([S1 Fig](#pone.0176261.s001){ref-type="supplementary-material"}) \[[@pone.0176261.ref010]\]. A computerized search was performed to identify all relevant studies published from January 1, 1947, to March 1, 2016, in the Medline, EMBASE and Cochrane Library database. The following search terms were used: *penetrating keratoplasty* and *corneal transplantation*. Citations were screened at the title and abstract level and retrieved as a full report if they reported on outcomes after PK. The search term "*glaucoma*" was then used in each retrieved paper to single out papers reporting data on PPKG. [S2 Fig](#pone.0176261.s002){ref-type="supplementary-material"} shows the search strategy used for each database. The full texts and bibliography of all potential articles were also reviewed in detail to search for additional relevant studies. In addition, a Google search was performed to locate relevant publications from national corneal transplantation registry web sites.

### Inclusion criteria {#sec008}

Studies were included if the following criteria applied: 1) reported on incidence or risk factors for PPKG; 2) reported to have included consecutive patients; 3) performed a minimum of 30 PK procedures; and 4) enrollment for PK was based on existing and accepted guidelines. When two or more publications were based on the same population, the publication with a larger sample size was included in the analysis.

### Exclusion criteria {#sec009}

Studies were excluded if any of the following criteria applied: 1) duplicate publication, overlap of patients, subgroup studies of a main study; 2) outcome of interests was not clearly reported or was impossible to extract or calculate from the results; and 3) a graft other than fresh donor cornea (e.g., keratoprosthesis, glycerol-preserved donor cornea) was used.

### Definitions {#sec010}

For the purpose of our current search and analysis, PPKG was defined as ocular hypertension (\> 21mmHg) after PK.

### Data extraction and quality assessment {#sec011}

Data were independently extracted from eligible studies by two reviewers. Relevant information was collected and included but was not limited to, year and journal of publication, first author, study design, inclusion and exclusion criteria, IOP measurement methods, definition of endpoints, number of subjects included, study population demographics, follow-up period, and outcomes. The study quality was also assessed in terms of prospective study design (prospective vs. retrospective) and multivariate statistical analyses (univariate vs. multivariate logistic regression) \[[@pone.0176261.ref011]\].

Statistical analysis {#sec012}
--------------------

The proportion of individuals with PPKG in each study was logit transformed, meta-analyzed and back-transformed to obtain a pooled incidence of PPKG for all studies. The incidence of PPKG was compared according to preexisting glaucoma, bullous keratopathy (BK), aphakia, pseudophakia, triple procedure, regrafting, and surgical indications including herpes simplex keratitis (HSK) and trauma, using an odd ratio (OR) with a 95% confidence interval (CI). Data were pooled using a DerSimonian-Laird's random-effects model to obtain a more conservative estimate of the incidence of PPKG and the odds of PPKG in these various groups \[[@pone.0176261.ref012],[@pone.0176261.ref013]\]. Statistical significance was set at p \< 0.05 (2-tailed). Heterogeneity was assessed by H^2^ and I^2^ test. The robustness of our findings was also analyzed by omitting one study at a time. In addition, publication bias was monitored and tested using funnel plots and fail-safe N (Rosenthal's for incidence analysis and Orwin's for risk factor analysis) when more than 10 studies were involved \[[@pone.0176261.ref014]\]. In risk factor analysis, criterion for a 'trivial' OR was set as 1.05, and the mean OR for missing studies was set as 1.00. If a publication bias was observed, the corresponding incidence or OR along with the CI was subsequently adjusted by Duval and Tweedie's trim and fill \[[@pone.0176261.ref015]\]. Data analysis was performed using Comprehensive Meta Analysis Version 2 (Biostat Inc., Englewood, NJ), except the confidence intervals for I^2^ which were calculated manually using the formulae from Higgins *et al* \[[@pone.0176261.ref016]\].

Results {#sec013}
=======

Through a keywords search, 19667 reports were identified and reviewed at the title and abstract level. Further evaluation narrowed the selection to 76 potential publications. A manual search of the bibliographies identified 2 additional relevant publications. When the inclusion and exclusion criteria were applied, 31 articles remained ([S1 Fig](#pone.0176261.s001){ref-type="supplementary-material"}). Of the 31 publications, 30 were used for assessing the incidence of PPKG ([Table 1](#pone.0176261.t001){ref-type="table"}), and 18 publications remained for assessing the risk factors of PPKG ([Table 2](#pone.0176261.t002){ref-type="table"}). Two of the 31 papers came from one center; however, one was used for assessing incidence \[[@pone.0176261.ref005]\] and the other was used for assessing the risk factors of PPKG \[[@pone.0176261.ref006]\]. The studies included in the analysis were from 14 countries and were published between 1972 (when the earliest PKKG report was found) and 2015. The 30 publications included for the incidence of PPKG had 7 prospective and 23 retrospective studies, and the remaining study \[[@pone.0176261.ref006]\] also had a retrospective design. Seven studies used Definition III, the strictest PPKG definition, among 30 selected papers \[[@pone.0176261.ref005],[@pone.0176261.ref017]--[@pone.0176261.ref022]\], and 5 articles reported an incidence of PPKG that excluded steroid-induced glaucoma \[[@pone.0176261.ref020],[@pone.0176261.ref022]--[@pone.0176261.ref025]\]. Nine surveys reported early incidence of PPKG, though the definition of "early" varied from 2 days to 3 months \[[@pone.0176261.ref018],[@pone.0176261.ref020],[@pone.0176261.ref022]--[@pone.0176261.ref024],[@pone.0176261.ref026]--[@pone.0176261.ref029]\].

10.1371/journal.pone.0176261.t001

###### Selected studies on the incidence of PPKG.

![](pone.0176261.t001){#pone.0176261.t001g}

  First Author   Center      Year   Study design    Subjects   Mean follow-up   IOP measurement approach                                        PPKG definition
  -------------- ----------- ------ --------------- ---------- ---------------- --------------------------------------------------------------- -----------------
  Sharma RA      UK          2016   Retrospective   35         24 months        Goldmann[\*](#t001fn002){ref-type="table-fn"}                   I
  Chen           China       2015   Prospective     108        384 days         Not mentioned                                                   II
  Oruçoglu       Israel      2014   Retrospective   146        24.4 months      Goldmann                                                        I
  Yu             Germany     2014   Retrospective   377        39.3 months      Not mentioned                                                   II
  Sharma A       India       2014   Retrospective   445        32 months        Goldmann                                                        I
  Huber          Germany     2013   Retrospective   1848       24 months        Goldmann                                                        III
  Yildirim       Turkey      2011   Retrospective   122        38.9 months      Tono-Pen[^†^](#t001fn003){ref-type="table-fn"}                  III
  Anshu          Singapore   2011   Prospective     901        36.8 months      Not mentioned                                                   I
  Karadag        Turkey      2010   Retrospective   749        5 months         Not mentioned                                                   III
  Wagoner        Saudi       2009   Retrospective   910        Not mentioned    Not mentioned                                                   III
  Rahman         UK          2009   Retrospective   203        61 months        Not mentioned                                                   III
  Williams       Australia   2007   Retrospective   13350      \> 1 year        Not mentioned                                                   I
  Patel          USA         2005   Prospective     388        Not mentioned    Not mentioned                                                   II
  Allouch        France      2003   Prospective     410        33.2 months      Goldmann                                                        II
  França         Brazil      2002   Retrospective   228        17.1 months      Not mentioned                                                   II
  Sit            Canada      2001   Retrospective   468        37.7 months      Not mentioned                                                   I
  Nguyen         Germany     2000   Retrospective   534        2.7 years        Goldmann                                                        I
  Redbrake       Germany     2000   Prospective     75         60 months        Goldmann                                                        I
  Xie            China       2000   Retrospective   1500       Not mentioned    Pneumotonometry                                                 I
  Wylegala       Poland      1999   Retrospective   537        Not mentioned    Pneumotonometry                                                 II
  Sihota         India       1998   Retrospective   747        23 months        Goldmann                                                        III
  Sekhar         India       1993   Retrospective   232        14.5 months      Goldmann                                                        I
  Chien          USA         1993   Prospective     155        1 week           Tono-Pen[^†^](#t001fn003){ref-type="table-fn"}                  I
  Kirkness       UK          1992   Retrospective   1122       Not mentioned    Not mentioned                                                   III
  Simmons        USA         1989   Retrospective   229        84 weeks         Goldmann                                                        I
  Foulks         USA         1987   Retrospective   502        3 years          Goldmann or Mackay-Marg[^‡^](#t001fn004){ref-type="table-fn"}   II
  Karesh         USA         1983   Retrospective   80         22 months        Pneumotonometry                                                 I
  Kushwaha       India       1981   Retrospective   185        15 days          Not mentioned                                                   I
  Goldberg       USA         1981   Prospective     137        Not mentioned    Not mentioned                                                   I
  Wood           USA         1972   Retrospective   423        Not mentioned    Mackay-Marg[^‡^](#t001fn004){ref-type="table-fn"}               I

PPKG, post penetrating keratoplasty glaucoma; I, ocular hypertension (\> 21mmHg) after penetrating keratoplasty; II, ocular hypertension (\> 21mmHg) after penetrating keratoplasty, which needed an anti-glaucoma surgical procedure or medications to lower intraocular pressure for more than 4 weeks; III, the presence of persistent elevated intraocular pressure, above 21 mmHg or \> 10 mmHg from the baseline value, that required the introduction of anti-glaucoma drops or surgical intervention at any time. In patients with pre-existing glaucoma, PPKG was defined as uncontrolled intraocular pressure with the original treatment regime that required escalation of treatment after penetrating keratoplasty.

\* Goldmann applanation tonometry.

^†^ Tono-Pen tonometry.

^‡^ Mackay-Marg electronic applanation tonometer.

10.1371/journal.pone.0176261.t002

###### Included studies on the risk factors for PPKG.

![](pone.0176261.t002){#pone.0176261.t002g}

  First Author   Subjects   Regression Model   Included on the risk factors for PPKG                                 
  -------------- ---------- ------------------ --------------------------------------- ---- ---- ---- ---- ---- ---- ----
  Oruçoglu       146        M                  \+                                                                    
  Sharma A       445        M                  \+                                      \+                            \+
  Yildirim       122        M                  \+                                      \+                            
  Karadag        749        U                  \+                                      \+   \+   \+   \+   \+   \+   
  Rahman         203        U                                                          \+                       \+   
  Al-Mohaimeed   715        M                  \+                                      \+   \+   \+             \+   
  Allouch        410        U                                                          \+                       \+   
  França         228        U                                                          \+             \+   \+   \+   
  Nguyen         534        U                                                                                        \+
  Redbrake       75         U                  \+                                                                    
  Sekhar         232        U                                                          \+   \+   \+             \+   \+
  Sihota         747        U                                                          \+   \+   \+             \+   
  Chien          155        M                  \+                                                                    \+
  Kirkness       1122       U                                                          \+             \+   \+        
  Simmons        229        U                  \+                                           \+   \+                  
  Foulks         502        U                  \+                                           \+   \+                  
  Karesh         80         U                  \+                                           \+                       
  Goldberg       137        U                                                          \+             \+   \+   \+   

PPKG, post penetrating keratoplasty glaucoma; BK, bullous keratopathy (either aphakic or pseudophakic); HSK, herpes simplex keratitis; U, univariate regression medel; M, multivariate regression model.

\* Either preoperative or at-graft.

^†^ Penetrating keratoplasty + extra capsular cataract extraction (ECCE) + intraocular lens (IOL) implantation.

An analysis of the incidence was performed on 27146 patients. The sample size varied from 35 \[[@pone.0176261.ref008]\] to 13350 \[[@pone.0176261.ref030]\] ([Table 1](#pone.0176261.t001){ref-type="table"}). Indications for PK were collected (see Appendix 1). The IOP was measured by Goldmann applanation tonometry in 5203 patients (19.2%) of 11 publications and was measured by the Tono-Pen tonometry in 277 patients (1.0%) in 2 studies. Two studies used Mackay-Marg electronic applanation tonometer in 925 subjects (3.4%). In addition, another three studies used pneumotonometry to measure IOP in 2153 subjects (7.9%). The IOP measurement approach was not mentioned in the remaining 19126 patients (70.5%).

The exact definition of PPKG varied among the selected studies. Basically, they could be classified into three subtypes:

1.  Ocular hypertension (\> 21mmHg) after PK.

2.  Ocular hypertension (\> 21mmHg) after PK (I), which needed an anti-glaucoma surgical procedure or medications to lower IOP for more than 4 weeks.

3.  The presence of persistent elevated IOP above 21 mmHg or \> 10 mmHg from the baseline value that required the introduction of anti-glaucoma drops or surgical intervention at any time, with or without visual field loss and/or optic nerve changes. In patients with pre-existing glaucoma, PPKG was defined as uncontrolled IOP with the original treatment regime that required an "escalation of treatment" after PK.

The pooled estimate for the overall incidence of PPKG was 21.5% (95% CI: 17.8 to 25.7, I^2^ = 97.4%; [Table 3](#pone.0176261.t003){ref-type="table"}, [Fig 1](#pone.0176261.g001){ref-type="fig"}). The value varied according to different filtering criteria ([Table 3](#pone.0176261.t003){ref-type="table"}), including the three definitions that were presented previously. The lowest incidence reported was 5.3% in a study from China using the Definition I criteria, while the highest incidence was 60%, which was reported in a United Kingdom survey that used the Definition I criteria. In addition, the incidence was similar between prospective and retrospective study groups.

![Forest plot for the pooled incidence of PPKG Definition I.\
The pooled estimate for the overall incidence (Definition I) of PPKG was 21.5% (95% CI: 17.8 to 25.7). PPKG, post-penetrating keratoplasty glaucoma.](pone.0176261.g001){#pone.0176261.g001}

10.1371/journal.pone.0176261.t003

###### Incidence of PPKG according to various filters.

![](pone.0176261.t003){#pone.0176261.t003g}

  Filtering criteria                               Number of studies   Number of subjects   Pooled incidence (%)   95% CI (%)   H^2^   I^2^ (%)   95% CI of I^2^ (%)
  ------------------------------------------------ ------------------- -------------------- ---------------------- ------------ ------ ---------- --------------------
  All (Definition I, II & III)                     30                  27146                21.5                   17.8, 25.7   38.5   97.4       95.6, 98.4
  Definition II & III                              14                  8251                 19.2                   14.4, 25.1   31.7   96.9       93.1, 98.5
  Definition III                                   7                   5701                 15.4                   11.7, 20.0   13.7   93.7       75.4, 97.9
  Early incidence                                  9                   5149                 11.9                   7.6, 18.4    23.3   95.7       87.5, 98.5
  Steroid-induced PPKG excluded                    5                   3464                 17.4                   11.5, 25.6   22.2   95.5       78.5, 97.9
  Definition III & Steroid-induced PPKG excluded   2                   2597                 12.1                   6.3, 22.0    29.4   96.6       \-
  Prospective                                      7                   2174                 22.4                   15.5, 31.3   17.2   94.2       80.2, 98.2
  Retrospective                                    23                  24972                21.3                   17.1, 26.1   41.7   97.6       95.7, 98.7
  **Using Goldmann Tonometer**                     11                  5203                 22.5                   14.7, 32.8   43.5   97.7       94.2, 99.1

PPKG, post penetrating keratoplasty glaucoma; CI, confident interval; Definition I, ocular hypertension (\> 21mmHg) after penetrating keratoplasty; Definition II, ocular hypertension (\> 21mmHg) after penetrating keratoplasty, which needed an anti-glaucoma surgical procedure or medications to lower intraocular pressure for more than 4 weeks; Definition III, the presence of persistent elevated intraocular pressure, above 21 mmHg or \> 10 mmHg from the baseline value, that required the introduction of anti-glaucoma drops or surgical intervention at any time. In patients with pre-existing glaucoma, PPKG was defined as uncontrolled intraocular pressure with the original treatment regime that required escalation of treatment after penetrating keratoplasty.

Our search for predictors of PPKG identified 18 publications on 8 major **factors** ([Table 4](#pone.0176261.t004){ref-type="table"}). The pooled incidence was much higher in those with preexisting glaucoma and in aphakic individuals, and was slightly higher in those with BK, pseudophakia, regrafting and preoperative diagnosis as trauma. The combination procedure of PK with extra capsular cataract extraction (ECCE) + intraocular lens (IOL) implantation seemed to be insignificantly associated with the increasing incidence of PKKG. Notably, the results remain similar when only high quality (using multivariate regression) studies were included. The pooled OR for trauma with PPKG became insignificant on removal of the studies by Kirkness et al \[[@pone.0176261.ref017]\]. Nevertheless, there was a trend toward an increased incidence.

10.1371/journal.pone.0176261.t004

###### Association of various factors with PPKG according to pooled OR.

![](pone.0176261.t004){#pone.0176261.t004g}

  Risk factor                                              Number of studies   Number of subjects   Pooled OR (95% CI)   H^2^   I^2^ (%)   95% CI of I^2^ (%)   Removed study that made pooled OR insignificant
  -------------------------------------------------------- ------------------- -------------------- -------------------- ------ ---------- -------------------- -------------------------------------------------
  Preexisting glaucoma                                     10                  3214                 5.50 (2.86, 10.58)   6.17   83.8       56.9, 93.9           None
  -Studies using multivariate model                        5                   1583                 3.50 (1.78, 6.74)    2.85   64.9       \-                   None
  BK[\*](#t004fn002){ref-type="table-fn"}                  11                  5195                 2.00 (1.46, 2.74)    3.38   70.4       25.3, 88.2           None
  -Studies using multivariate model                        3                   1282                 1.90 (1.19, 3.02)    1.82   45.0       \-                   None
  Aphakia[\*](#t004fn002){ref-type="table-fn"}             8                   3254                 4.23 (2.78, 6.43)    3.00   66.7       \-                   None
  Pseudophakia[\*](#t004fn002){ref-type="table-fn"}        6                   3164                 1.56 (0.93, 2.61)    4.41   77.3       10.2, 94.2           None
  HSK                                                      4                   2388                 1.08 (0.49, 2.35)    1.45   30.9       \-                   \-
  Trauma                                                   4                   2234                 2.62 (1.21, 5.68)    2.39   58.2       \-                   Kirkness et al.
  Regraft                                                  8                   3487                 1.83 (1.05, 3.19)    4.27   76.6       27.0, 92.5           None
  Triple procedure[^†^](#t004fn003){ref-type="table-fn"}   4                   1366                 0.92 (0.37, 2.28)    5.15   80.6       \-                   \-
  -Studies using multivariate model                        2                   600                  0.99 (0.20, 4.84)    5.78   82.6       \-                   \-

PPKG, post penetrating keratoplasty glaucoma; OR, odd ratio; CI, confidence interval; BK, bullous keratopathy (either aphakic or pseudophakic); HSK, herpes simplex keratitis.

\* Either preoperative or at-graft.

^†^ Penetrating keratoplasty + extra capsular cataract extraction (ECCE) + intraocular lens (IOL) implantation.

[Table 5](#pone.0176261.t005){ref-type="table"} and [Fig 2](#pone.0176261.g002){ref-type="fig"} showed the publication bias analyses for all that included more than 10 studies. All the fail-safe N values remained considerably large except that for BK which was a little smaller but still large. In addition, analysis for BK was the only one that had a pooled value change under Duval and Tweedie's trim and fill, suggesting that a publication bias might exist and a more "real" OR might be close to 1.87. Nevertheless, this "real" value was very close to what was calculated.

10.1371/journal.pone.0176261.t005

###### Publication bias analysis.

![](pone.0176261.t005){#pone.0176261.t005g}

  Study Criteria             Number of Studies    Fail-safe N                                  Pooled value (95% CI)                                     Pooled value (95% CI) adjusted with Duval and Tweedie's trim and fill   
  -------------------------- -------------------- -------------------------------------------- --------------------------------------------------------- ----------------------------------------------------------------------- ----------------------------------------------------------
  Incidence                  All (Definition I)   30                                           84130[\*](#t005fn002){ref-type="table-fn"}                21.5 (17.8, 25.7)[^‡^](#t005fn004){ref-type="table-fn"}                 21.5 (17.8, 25.7) [^‡^](#t005fn004){ref-type="table-fn"}
  Definition II              14                   7937[\*](#t005fn002){ref-type="table-fn"}    19.2 (14.4, 25.1)[^‡^](#t005fn004){ref-type="table-fn"}   19.2 (14.4, 25.1) [^‡^](#t005fn004){ref-type="table-fn"}                
  Retrospective              23                   24927[\*](#t005fn002){ref-type="table-fn"}   21.3 (17.1, 26.1)[^‡^](#t005fn004){ref-type="table-fn"}   21.3 (17.1, 26.1) [^‡^](#t005fn004){ref-type="table-fn"}                
  Using Goldmann Tonometer   11                   2965[\*](#t005fn002){ref-type="table-fn"}    22.5 (14.7, 32.8)[^‡^](#t005fn004){ref-type="table-fn"}   22.5 (14.7, 32.8) [^‡^](#t005fn004){ref-type="table-fn"}                
  Risk Factor                BK                   11                                           168[^†^](#t005fn003){ref-type="table-fn"}                 2.00 (1.46, 2.74)[^§^](#t005fn005){ref-type="table-fn"}                 1.87 (1.36, 2.57)[^§^](#t005fn005){ref-type="table-fn"}

BK, bullous keratopathy (either aphakic or pseudophakic)

\* Rosenthal's fail-safe N

^†^ Orwin's fail-safe N

^‡^ Pooled incidence (%)

^§^Pooled Odd Ratio

![Funnel plots of publication bias analyses for PPKG incidence (A-D) and a risk factor (E, BK).\
Incidences filtered by Definition I (A), Definition II (B), retrospective studies only (C) and studies using Goldmann tonometer (D) were tested for potential publication bias. PPKG, post penetrating keratoplasty glaucoma; BK, Bullous keratopathy.](pone.0176261.g002){#pone.0176261.g002}

Discussion {#sec014}
==========

This systematic review and meta-analysis included data from all available and identified studies that reported the incidence of PPKG. The reported incidence varied strikingly, and, as was mentioned, there is no "gold standard" of PPKG diagnosis. As was found in our results, the PPKG definition, no matter I, II or III, was significantly distinguished from the classic definition of glaucoma. A major potential reason may be the widely-acknowledged difficulty to perform visual field assessment and fundus imaging for post-PK patients. In our study, the definition criteria used were found to lead to the different incidences, which was lowest when Definition III criteria were used and highest with a broad definition of PPKG (Definition I). Because Definition III is the strict and universally acknowledged PPKG definition, it could be inferred that the real incidence of PK-induced glaucoma might be close to 15.4%. In terms of the exclusion of steroid-induced PPKG, the incidences were 17.4% and 12.1% in all patients and in those that fit the Definition III criteria; however, among the PPKG patients of the two groups, the proportions of those without steroid-induced PPKG remained similar (77.7% and 78.6%), which suggested that the use of steroids after PK might contribute to a 21--22% proportion of intraocular hypertension or PPKG. In addition, early incidence of PPKG was approximately half of the overall incidence. Although the definition of "early" varied in the studies, it can still be inferred that PPKG occurs in different time periods according to diverse pathogenic factors and that almost half of PPKG cases may arise in the early period after PK.

According to the definitions used in this study, an IOP of 21mmHg was set as a critical value; however, regarding the extracted data, IOP was measured using different methods with diverse sensitivity and reliability. Moreover, Goldmann applanation tonometry has been considered the ''gold standard" in IOP measurement, which may explain the reason that this device was most frequently used among the reported IOP measurement approaches, but it may provide inaccurate results in an edematous cornea or in a corneal transplant \[[@pone.0176261.ref031]\]. In fact, animal studies and ex vivo systems have suggested less accuracy with Goldmann applanation tonometry, whereas MacKay-Marg and Tono-Pen tonometers in corneas with edema and corneal transplants have been more reliable \[[@pone.0176261.ref031],[@pone.0176261.ref032]\]. Therefore, the IOP could be measured with biases after PK, due to the diverse accuracy and reliability of the methods adapted, thus affecting PPKG identification.

The results of our study showed that preexisting glaucoma seemed to be a leading cause of PKKG. Previous studies indicated that preexisting glaucoma was also a major risk factor for graft failure \[[@pone.0176261.ref033],[@pone.0176261.ref034]\]. Hence, IOP control is important before PK in this patient population. However, PPKG may still occur even when glaucoma was medically controlled preoperatively \[[@pone.0176261.ref029]\]. A particularly significant association of BK with PKKG was also found. As BK was the leading indication for keratoplasty in many countries and the majority of the pseudophakic and aphakic cases were associated with BK, it is not suitable to consider pseudophakia and aphakia as independent risk factors \[[@pone.0176261.ref021]\]. Probable explanations for the increased PKKG incidence in these cases include IOL material, inflammatory response after PK, the effects of aphakia and pseudophakia on the peripheral anterior angle structures, and the synechia formation \[[@pone.0176261.ref021],[@pone.0176261.ref035]\].

A moderate association between regrafting and PPKG was indicated, which may attribute to a strong inflammatory response and poor peripheral anterior angle structures after PK. Surgical indication of trauma was also found to be related to more prevalent incidence of PKKG. However, as the robustness of the analysis was suggested, this result should be conservatively interpreted.

Previous study results regarding the association of a triple procedure (combined PK with ECCE and IOL implantation) with PKKG have aroused controversy \[[@pone.0176261.ref001]\]. Our results suggested that there was no strong evidence to prove this relevance. As phacoemulsification has predominated in industrialized countries \[[@pone.0176261.ref036]\], the combination of PK with phacoemulsification and IOL implantation has, therefore, been widely used in these areas \[[@pone.0176261.ref037]\]. Thus, the association of this combined procedure with PKKG should also be studied in the future.

The aetiology and pathogenesis of PKKG are multifactorial and complicated, causing some potential risk factors to remain undiscovered. Olson and Kaufman identified several other variables that could possibly alter the anterior chamber angle and thus increase the IOP using a mathematical model, including tight suturing, long suture bites, and same-sized donor-recipient trephination \[[@pone.0176261.ref038]\]. Due to our inclusion and exclusion criteria and limited article selection, these factors were unable to be meta-analyzed in this study. However, they are potential predictors of PKKG that should also be considered pre- and postoperatively.

High heterogeneity between studies was observed in our results. The reasons for the heterogeneity are speculative but may include subtle differences in the way diagnostic criteria for PPKG were defined, or in other cultural differences, including ethnicity, which were not possible to examine using the available data. Also, the large objective number is also directly linked with high heterogeneity \[[@pone.0176261.ref039]\]. We performed several sensitivity analyses based on various criteria (Tables [3](#pone.0176261.t003){ref-type="table"} & [4](#pone.0176261.t004){ref-type="table"}), and found that the results remain similar, which suggests the reliability of our analyses. Although heterogeneity may be seen as precluding the pooling of data from these studies in a meta-analysis, we feel that the summary data obtained using our approaches are useful in viewing the incidence and predictors of PPKG from an epidemiological and global perspective.

This study has several strengths. An exhaustive search strategy was used to maximize the likelihood of identifying all pertinent literature. Eligibility and data extraction was judged independently by two investigators, and discrepancies were resolved by consensus. We included data from eligible foreign language papers to be as inclusive as possible. A random effects model was used to pool data in order to provide a more conservative estimate of the incidence of PPKG and was assessed for publication bias. Finally, we limited studies to those with consecutive patients and excluded those conducted with \< 30 sample sizes, meaning that the likelihood that the incidence of PPKG was inflated has been minimized.

This study also has some limitations. All studies included were single-centered, except the Australian Corneal Graft Registry Report \[[@pone.0176261.ref030]\], decreasing the generalizability and increasing the likelihood of environmental and socio-economic bias. From the global perspective, the absence of studies that have reported on the incidence and risk factors for PKKG for some geographical regions, such as Africa and Central America, is another limitation for the generalizability of this meta-analysis. In addition, as mentioned, diverse IOP-measuring methods contributed to PPKG identification bias.

The findings of this study have implications for both clinical practice and future research. Studies using the Definition III criteria to define PKKG remain scarce, although these criteria have been used and published since 1992 \[[@pone.0176261.ref017]\]. Extracting and analyzing study data on the incidence of PPKG has emphasized the magnitude of this complication after PK and thus the implications for health services worldwide. Our findings also revealed the importance of determination of corticosteroid dosing in addition to anti-glaucoma management for treating PKKG and strengthened the consensus that tapering off corticosteroid and using "substitutes", e,g., cyclosporine A, after PK seemed to be a recommendable choice \[[@pone.0176261.ref040]\]. Moreover, as the third most common cause for graft failure after PK, the incidence and predictors of PPKG in some geographical regions, such as Africa and Central America, need further study.

Conclusions {#sec015}
-----------

This systematic review and meta-analysis has demonstrated an incidence of PPKG of almost 21.5%, but this varied, considerably in some instances, according to the diagnostic criteria and other factors such as IOP measurement methods, corticosteroid use, and follow-up time after PK. Strong risk factors for PKKG included preexisting glaucoma and aphakia, and minor risk factors included pseudophakia, regrafting, and preoperative diagnosis as BK and trauma. In addition, there may not be sufficient evidence to identify a significant association between a triple procedure and the increased incidence of PKKG.
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